Dr. Jason Valentine

About Jason
Jason draws on his pharmaceutical industry experience in synthetic organic chemistry, polymorphism, bioprocesses, drug discovery, analytical chemistry and formulation science to advise clients in the life science industries with a particular emphasis on pharmaceutical research and development.
Passions
Science
Family
Endurance Sports
Experience
-
MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement
-
MapLight Therapeutics Closes Oversubscribed $372.5 Million Series D
-
Nuvation Bio Announces up to $250 Million Nondilutive Financings From Sagard Healthcare Partners
-
Geron Corporation Announces up to $375 Million in Funding With Royalty Pharma and Pharmakon Advisors
-
MapLight Therapeutics Closes Oversubscribed $225 Million Series C
Admissions and credentials
- District of Columbia
- US Patent and Trademark Office
Get In Touch
Location
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.